Middle East and Africa Dermatological Therapeutics Market 2019-2028

2.1. Market Definition
2.2. Key Insights
2.2.1. Advancements in Biologics
2.2.2. Atopic Dermatitis is Anticipated to Grow at Highest CAGR
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Impact of COVID-19 – Dermatological Therapeutics
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Increasing Burden of Dermatological Diseases
2.8. Market Restraints
2.8.1. Grave Side-Effects for Certain Classes of Therapeutic Drugs
2.9. Market Opportunities
2.9.1. Rise in Awareness Levels of Disease Origin and Progression
2.10. Market Challenges
2.10.1. Unawareness Towards Dermatological Diagnosis

3.1. Anti-Infectives
3.2. Corticosteroids
3.3. Anti-Acne
3.4. Calcineurin Inhibitors
3.5. Retinoids
3.6. Other Drug Classes

4.1. Alopecia
4.2. Herpes
4.3. Psoriasis
4.4. Rosacea
4.5. Atopic Dermatitis
4.6. Acne Vulgaris
4.7. Other Applications

5.1. Middle East and Africa
5.1.1. United Arab Emirates
5.1.2. Turkey
5.1.3. Saudi Arabia
5.1.4. South Africa
5.1.5. Rest of Middle East & Africa

6.1. Abbvie Inc
6.2. Allergan
6.3. Almirall
6.4. Amgen Inc
6.5. Bausch Health Companies Inc
6.6. Galderma
6.7. GlaxoSmithKline plc
6.8. Johnson & Johnson
6.9. Novartis Ag
6.10. Pfizer Inc
6.11. AGI Dermatics
6.12. Leo Pharma A/S
6.13. Merck & Co

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

Table 1: Middle East and Africa Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Middle East and Africa Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 5: Middle East and Africa Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 6: Middle East and Africa Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)

Figure 1: Porter's Five Forces Analysis
Figure 2: Middle East and Africa Dermatological Therapeutics Market, by Anti-Infectives, 2019-2028 (In $ Billion)
Figure 3: Middle East and Africa Dermatological Therapeutics Market, by Corticosteroids, 2019-2028 (In $ Billion)
Figure 4: Middle East and Africa Dermatological Therapeutics Market, by Anti-Acne, 2019-2028 (In $ Billion)
Figure 5: Middle East and Africa Dermatological Therapeutics Market, by Calcineurin Inhibitors, 2019-2028 (In $ Billion)
Figure 6: Middle East and Africa Dermatological Therapeutics Market, by Retinoids, 2019-2028 (In $ Billion)
Figure 7: Middle East and Africa Dermatological Therapeutics Market, by Other Drug Classes, 2019-2028 (In $ Billion)
Figure 8: Middle East and Africa Dermatological Therapeutics Market, by Alopecia, 2019-2028 (In $ Billion)
Figure 9: Middle East and Africa Dermatological Therapeutics Market, by Herpes, 2019-2028 (In $ Billion)
Figure 10: Middle East and Africa Dermatological Therapeutics Market, by Psoriasis, 2019-2028 (In $ Billion)
Figure 11: Middle East and Africa Dermatological Therapeutics Market, by Rosacea, 2019-2028 (In $ Billion)
Figure 12: Middle East and Africa Dermatological Therapeutics Market, by Atopic Dermatitis, 2019-2028 (In $ Billion)
Figure 13: Middle East and Africa Dermatological Therapeutics Market, by Acne Vulgaris, 2019-2028 (In $ Billion)
Figure 14: Middle East and Africa Dermatological Therapeutics Market, by Other Applications, 2019-2028 (In $ Billion)
Figure 15: Middle East and Africa Dermatological Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 16: United Arab Emirates Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 17: Turkey Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 18: Saudi Arabia Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 19: South Africa Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 20: Rest of Middle East & Africa Dermatological Therapeutics Market 2019-2028 (In $ Billion)